Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
26.99
+1.42 (5.55%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.61 billion as of June 12, 2026. Its market cap has increased by 226.31% in one year.
Market Cap
1.61B
Enterprise Value
1.23B
1-Year Change
226.31%
Ranking
Category
Stock Price
$26.99
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.61B, an increase of 145.19%. That is a compound annual growth rate of 20.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.61B | 14.39% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.64B |
| Ascentage Pharma Group International | 1.64B |
| AnaptysBio | 1.63B |
| Sionna Therapeutics | 1.62B |
| Septerna | 1.62B |
| Syndax Pharmaceuticals | 1.62B |
| Sarepta Therapeutics | 1.62B |
| AbCellera Biologics | 1.60B |